13 patents currently held

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Nov 2037. from the record

Free plan: 3 watched companies. Pro: unlimited.

Alerts on its grants, lapses and transfers.

Ending by 2030

Nov 2037

Next term end

Patent families

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

202620272028202920302031203220332034203520362037 2038 2039 2040 2041 2042204320442045

notable patents all others Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Notable: the highest-ranked patents in this portfolio by citations and family size.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank

Notable

Particles Comprising a Therapeutic or Diagnostic Agent and Suspensions and Methods of Use Thereof US 11,654,112

Cited by 14 later US patents, top 5% of utility patents granted in 2023 in our data. Protection runs to 2040.

Ends Sep 2040 · High confidence Also notable

Particle Formation And Morphology US 11,717,488

Cited by 11 later US patents, top 10% of utility patents granted in 2023 in our data. Protection runs to 2040. A terminal disclaimer caps this term to an earlier patent's.

Ends Jan 2040 · Low confidence Also notable

Compositions and Methods for the Delivery of Therapeutic Biologics for Treatment of Disease US 11,459,376

Cited by 14 later US patents, top 10% of utility patents granted in 2022 in our data. Protection runs to 2040. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.

Ends no later than Sep 2040 · Low confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Feb 8, 2027
The maintenance fee for Particle Formation And Morphology (US 11,717,488) comes due Feb 8, 2027. Unpaid by Aug 9, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

The 5 largest of its 6 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Particles Comprising a Therapeutic or Diagnostic Agent and Suspensions and Methods of Use Thereof (2020)	3 in force	to Oct 2041
Particles Comprising a Therapeutic or Diagnostic Agent and Suspensions and Methods of Use Thereof (2019)	3 in force	to Sep 2040
Compositions and Methods for the Delivery of Therapeutic Biologics for Treatment of Disease	2 in force	to Sep 2040
Electrospraying Formation of Particles Including Agents	2 in force	to May 2040
Particle Formation And Morphology	2 in force	to Jan 2040

Patents held now

Soonest term end first.

Patent	Title	Status	Expires	Confidence
US 12,569,445	Particles Comprising a Therapeutic or Diagnostic Agent and Suspensions and Methods of Use Thereof In force Term ends Nov 22, 2037 · High confidence	In force	Term ends Nov 22, 2037	High confidence
US 12,178,913	Particles Comprising a Therapeutic or Diagnostic Agent and Suspensions and Methods of Use Thereof In force Term ends Jan 16, 2038 · High confidence	In force	Term ends Jan 16, 2038	High confidence
US 11,077,059	Electrospraying Formation of Particles Including Agents In force Term ends Jul 25, 2038 · High confidence	In force	Term ends Jul 25, 2038	High confidence
US 12,263,253	Particles Comprising a Therapeutic or Diagnostic Agent and Suspensions and Methods of Use Thereof In force Term ends May 24, 2039 · High confidence	In force	Term ends May 24, 2039	High confidence
US 12,433,849	Particles Comprising a Therapeutic or Diagnostic Agent and Suspensions and Methods of Use Thereof In force Term ends May 24, 2039 · High confidence	In force	Term ends May 24, 2039	High confidence
US 11,717,488	Particle Formation And Morphology In force Term ends Jan 30, 2040 · Low confidence	In force	Term ends Jan 30, 2040	Low confidence
US 12,558,323	Particle Formation And Morphology In force Term ends Jan 30, 2040 · Low confidence	In force	Term ends Jan 30, 2040	Low confidence
US 12,263,249	Formation of Particles Including Agents In force Term ends May 25, 2040 · High confidence	In force	Term ends May 25, 2040	High confidence
US 11,654,112	Particles Comprising a Therapeutic or Diagnostic Agent and Suspensions and Methods of Use Thereof In force Term ends Sep 9, 2040 · High confidence	In force	Term ends Sep 9, 2040	High confidence
US 11,459,376	Compositions and Methods for the Delivery of Therapeutic Biologics for Treatment of Disease In force Ends no later than Sep 11, 2040 · Low confidence	In force	Ends no later than Sep 11, 2040	Low confidence

10 of 13 patents shown.

Pro members see all 13.

Pro members: see all 13 patents

Also on record, not counted in the 13: 18 applications pending · 1 application abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built

Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Halozyme Hypercon, Inc.